Eastern Europe is a hotspot for global clinical trials. Why? Because it's cost-effective. However, this comes with a catch. The region has some gaps in research oversight and a shortage of local experts in research ethics. This raises a big question: Are participants in these trials at risk of being taken advantage of or harmed? This is a serious concern that needs ...